УДАЛЕННАЯ ДИАГНОСТИКА И ИНТЕГРАЦИЯ МЕДИЦИНСКИХ ДАННЫХ ДЛЯ ПОВЫШЕНИЯ ЭФФЕКТИВНОСТИ ЭЛЕКТРОКАРДИОТЕРАПИИ
Аннотация
Рассматриваются вопросы удаленного мониторинга пациентов с имплантируемыми устройствами, приводятся результаты исследования ReHoming, обсуждается возможность оценки вариабельности сердечного ритма в длительном наблюдении за пациентами.
Об авторах
А. Ш. Ревишвили
Институт хирургии им. А.В. Вишневского
Россия
Россия
Н. Н. Ломидзе
Научный центр сердечно-сосудистой хирургии им. А.Н. Бакулева
Россия
Россия
Р. Ш. Сунгатов
Dicom Consulting GmbH
Россия
Россия
И. Ш. Хасанов
Friedrich-Alexander University Erlangen-Nuremberg
Россия
Россия
Список литературы
1. Dubner S., Auricchio A., Steinberg J.S., et al. ISHNE/ EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace 2012; 14: 278 293.
2. Slotwiner D., Varma N., Akar J.G., et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm 2015; 12 (7): e69-e100.
3. Mabo P., Victor F., Bazin P., et al. A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial). European Heart Journal 2012; 33: 1105-1111.
4. Hindricks G., Taborsky M., Glikson M., et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. The Lancet 2014; 384 (9943): 583-590.
5. Sack S., Wende Ch.M., Nägele H., et al. Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: Results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study. European Journal of Heart Failure 2011; 13: 1019-1027.
6. Hutten H., Schaldach M. Telecardiology Optimizing the Diagnostic and Therapeutic Efficacy of the Next Implant Generation. Progress in Biomedical Research 1998; 3 (1): 1 4.
7. Wallbruck K., Stellbrink C., Santini M., et al. The Value of Permanent Follow-up of Implantable Pacemakers First Results of a European Trial. Biomed Tech (Berl) 2002; 47 (Suppl 1, Part 2): 950 9534.
8. Stellbrink C., Filzmaier K., Mischke K., et al. Potential Applications of Home Monitoring in Pacemaker Therapy A Review with Emphasis on Atrial Fibrillation and Congestive Heart Failure. Progress in Biomedical Research 2001; 6(2): 107 114.
9. Lazarus A. Remote, Wireless, Ambulatory Monitoring of Implantable Pacemakers, Cardioverter Defibrillators, and Cardiac Resynchronization Therapy Systems: Analysis of a Worldwide Database. PACE 2007; 30 (Supplement 1): S2 S12.
10. Thackray S.D., Witte K.K., Nikitin N.P., et al. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. Eur Heart J 2003; 24: 1143 1152.
11. Sweeney M.O., Hellkamp A.S., Ellenbogen K.A., et al., for the MOde Selection Trial (MOST) Investigators. Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation among Patients with Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction. Circulation 2003; 107: 2932-2937.
12. Vardas P.E., Auricchio A., Blanc J.J., et al. European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 2007; 28: 2256 2295.
13. Sharma A.D., Rizo-Patron C., Hallstrom A.P., DAVID Investigators. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005; 2: 830-834.
14. Tse H.F., Yu C., Wong K.K., et al. Functional abnormalities in patients with permanent right ventricular pacing: the effect of sites of electrical stimulation. J Am Coll Cardiol 2002; 40: 1451-1458.
15. O‘Keefe J.H. Jr., Abuissa H., Jones P.G. Effect of chronic right ventricular apical pacing on left ventricular function. Am J Cardiol 2005; 95: 771-773.
16. Fang F., Zhang Q., Chan J.Y. et al. Deleterious effect of right ventricular apical pacing on left ventricular diastolic function and the impact of pre-existing diastolic disease. Eur Heart J 2011; 32: 1891-1899.
17. Albertsen A.E., Mortensen P.T., Jensen H.K., et al. Adverse effect of right ventricular pacing prevented by biventricular pacing during long-term follow-up: a randomized comparison. Eur J Echocardiogr (2011) 12 (10): 767-772.
18. Wilkoff B.L., Cook J.R., Epstein A.E., et al. Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288: 3115-3123.
19. Chan J.Y., Fang F., Zhang Q. et al. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J 2011; 32 (20): 2533-2540. ВЕСТНИК АРИТМОЛОГИИ, № 85, 2016
20. Yu C.M., Chan J.Y., Zhang Q., et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009; 36: 2123-2134.
21. van Geldorp I.E., Vernooy K., Delhaas T., et al. Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace 2010; 12: 223 229.
22. Moak J.P., Hasbani K., Ramwell C., et al. Dilated cardiomyopathy following right ventricular pacing for AV block in young patients: resolution after upgrading to biventricular pacing systems. J Cardiovasc Electrophysiol 2006; 17: 1068 1071.
23. Zhang X.H., Chen H., Siu C.W., et al. New-onset heart failure after permanent right ventricular apical pacing in patients with acquired high-grade atrioventricular block and normal left ventricular function. J Cardiovasc Electrophysiol 2008; 19: 136 141.
24. Hayes J.J., Sharma A.D., Love J.C., et al. DAVID Investigators. Abnormal conduction increases risk of adverse outcomes from right ventricular pacing. J Am Coll Cardiol 2006; 48: 1628 1633.
25. Chung E.S., Katra R.P., Ghio S., et al. Cardiac resynchronization therapy may benefit patients with left ventricular ejection fraction. 35%: a PROSPECT trial substudy. Eur J Heart Fail 2010; 12: 581 587.
26. Funck R.C., Blanc J.J., Mueller H.H., et al. BioPace Study Group. Biventricular stimulation to prevent cardiac desynchronization: rationale, design, and endpoints of the ‘Biventricular Pacing for Atrioventricular Block to Prevent Cardiac Desynchronization (BioPace)’ study. Europace 2006; 8: 629 635.
27. Curtis A.B., Adamson P.B., Chung E., et al. Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): clinical study design and rationale. J Cardiovasc Electrophysiol 2007; 18: 965 971.
28. Fang F., Chan J.Y., Yip G.W., et al. Prevalence and determinants of left ventricular systolic dyssynchrony in patients with normal ejection fraction received right ventricular apical pacing: a real-time three-dimensional echocardiographic study. Eur J Echocardiogr 2010; 11: 109 118.
29. Varma N., Epstein A.E., Irimpen A., et al. for the TRUST Investigators. Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010; 122: 325-332.
30. Boriani G., Diemberger I., Martignani C. et al. Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. J Gen Intern Med 2008; 23(Suppl 1): 73-77.
31. Клинические рекомендации по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств. Всероссийское научное общество специалистов по клинической электрофизиологии, аритмологии и кардиостимуляции (ВНОА). Москва, 2011: 518 с.
32. Cleland J.G., Daubert J.C., Erdmann E et al. Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail 2005; 7: 205-214.
33. Bristow M.R., Saxon L.A., Boehmer J. et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
34. Bruch C., Bruch C., Sindermann J. et al. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator. Europace 2007; 9: 681-686.
35. Catanzariti D., Lunati M., Landolina M. et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol 2009; 32: 363-370.
36. Small R.S., Wickemeyer W., Germany R. et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail 2009; 15: 475-481.
37. Whellan D.J., Ousdigian K.T., Al-Khatib S.M. et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 2010; 55: 1803-1810.
38. Cleland J.G., Daubert J.C., Erdmann E. et al. Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail 2005; 7: 205-214.
39. Bristow M.R., Saxon L.A., Boehmer J. et al. Cardiac-re-synchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
40. Chatterjee N.A., Gallagher J.J., Ip J. et al. on behalf of the TRIAGE-CRT investigators. Telemonitoring in Patients with Congestive Heart Failure and Indication for ICD-Cardiac Resynchronization Therapy: TRIAGE-CRT. The Journal of Innovations in Cardiac Rhythm Management 2011; 2: 347 352.
41. http://www.carematix.com
42. http://www1.vde.com/wbb/pmm
43. http://www.biotronik.com
44. http://www.biovotion.com
45. https://helterbook.com
46. Halimi F., Clémenty J., Attuel P. et al. OEDIPE trial Investigators. Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial. Europace 2008; 10: 1392-1399.
47. Heidbüchel H., Lioen P., Foulon S. et al. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator. Europace 2008; 10: 351-357.
48. Kacet S., Guédon-Moreau L., Hermida J.-S. et al. on behalf of the ECOST trial Investigators. Safety and effectiveness of implantable cardioverter defibrillator follow-up using remote monitoring: ECOST study. European Society of Cardiology, Paris, 29 August 2011 http://www.escardio.org/congresses/esc-2011/congress-reports/Pages/707-2-ECOST.aspx
49. Бокерия Л.А. Гудкова Р.Г. Сердечно-сосудистая хирургия 2009. Болезни и врожденные аномалии системы кровообращения. НЦССХ им. А.Н. Бакулева, 2010 год.
50. Varma N., Ricci R.P. Telemedicine and cardiac implants: what is the benefit. European Heart Journal 2013.
51. Orlov M.V., Ghali J.K., Araghi-Niknam M. et al. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol 2007; 30: 404 411.
52. Schuchert A., Lepage S., Ostrander J.J. et al. Automatic analysis of pacemaker diagnostic data in the identification of atrial tachyarrhythmias in patients with no prior history of them. Europace 2005; 7: 242 247.
53. Elsner et al., REFORM Trial, A Prospective Multicenter Comparison Trial of Home Monitoring against Regular Follow-up in MADIT II Patients. Computers in Cardiology 2006; 33: 241-244.
54. Kolominsky-Rabas P.L., Heuschmann P.U., Marschall D., et al. for the CompetenceNet Stroke. Lifetime Cost of Ischemic Stroke in Germany: Results and National Projections from a Population-Based Stroke Registry. Stroke 2006, 37: 1179-1183.
55. Vogtmann T., Stiller S., Marek A. et al. Workload and usefulness of daily, centralized home monitoring for patients treated with CIEDs: results of the MoniC (Model Project Monitor Centre) prospective multicentre study. Europace Advance Access published November 9, 2012; doi: 10.1093/europace/eus25
56. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем (методические рекомендации). Вестник аритмологии 2001; № 24: 65-87.
57. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use. Circulation 1996; 93: 1043-1065.
58. Van de Borne P., Montano N., Pagani M., Oren R., Somers V.K. Absence of Low-Frequency Variability of Sympathetic Nerve Activity in Severe Heart Failure. Circulation 1997; 95: 1449-1454.
59. Selye H. Stress and Disease. Science 1955; 122 (3171): 625-631.
60. Selye H. A Syndrome Produced by Nocuous Agents. Nature 1936; 138 (3479): 32.
61. Stauss H.M. Heart rate variability. Am J Physiol Regulatory Integrative Comp Physiol 2003; 285: 927 931.
62. Williams T.D., Chambers J.B., Henderson R.P. et al. Cardiovascular responses to caloric restriction and thermoneutrality in C57BL/6J mice. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1459 R1467.
63. Aoki K., Stephens D.P., Johnson J.M. Diurnal variation in cutaneous vasodilator and vasoconstrictor systems during heat stress. Am J Physiol Regul Integr Comp Physiol 2001; 281: R591-R595.
64. Blumberg M.S., Knoot T.G., Kirby R.F. Neural and hormonal control of arterial pressure during cold exposure in un-anesthetized week-old rats. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1514-R1521.
65. Overton J.M., Williams T.D., Chambers J.B., Rashotte M.E. Cardiovascular and metabolic responses to fasting and thermoneutrality are conserved in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2001; 280: R1007-R1015.
66. Vornanen M., Ryokkynen A., Nurmi A. Temperature-dependent expression of sarcolemmal K+ currents in rainbow trout atrial and ventricular myocytes. Am J Physiol Regul Integr Comp Physiol 2002; 282: R1191-R1199.
67. Porter G.A. Jr., Rivkees S.A. Ontogeny of humoral heart rate regulation in the embryonic mouse. Am J Physiol Regul Integr Comp Physiol 2001; 281: R401-R407.
68. Penttilä J., Kuusela T., Scheinin H. Analysis of rapid heart rate variability in the assessment of anticholinergic drug effects in humans. Eur J Clin Pharmacol 2005; 61: 559 565.
69. Laitio T., Jalonen J., Kuusela T., Scheinin H. The Role of Heart Rate Variability in Risk Stratification for Adverse Postoperative Cardiac Events. Anesth Analg 2007; 105: 1548-1560.
70. Парин В.В., Баевский Р.М., Волков Ю.Н., Газенко О.Г. Космическая кардиология. Л., Медицина, 1967. 206 с.
71. Баевский Р.М., Берсенева А.П. Оценка адаптационных возможностей организма и риск развития заболеваний. М.: Медицина. 1997. 265 с.
72. Саркисов Д.С., Пальцын А.А., Втюрин Б.В. Приспособительная перестройка биоритмов (Электронноавторадиографическое исследование). М., „Медицина“, 1975, 184 с.
73. Physiologie des Menschen. Ed. R.F. Schmidt, G. Thews. Springer-Verlag. Berlin, Heidelberg, New York, Tokyo. 1985; p.
74. Хлопков А.М. Гистофизиологические особенности миокарда. Томск, 1948, 126 с.
75. Bonow R.O., Udelson J.E. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Ann Intern Med 1992; 117: 502-510.
76. Cohn J., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic heart failure. N Engl J. Med 1984; 311: 819-823.
77. Remme W.J. Prevention of worsening heart failure: future focus. Europ Heart J 1998; l9 (suppl lB): В47-В53.
78. Vasan R.S., Benjamin E.J., Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 15651574.
79. Мульдияров П.Я. Ультраструктура миокарда при различных режимах физической нагрузки. Дисс.. Канд. М., 1967, 234 с.
80. Саркисов Д.С., Втюрин Б.В. Электронномикроскопический анализ повышения выносливости сердца. М., «Медицина», 1969, 172 с.
81. Крыжановский Г.Н. Некоторые основные закономерности осуществления биологических процессов и их роль в патологии. „Пат. Физиол.“ 1974; № 6, с. 3-15.
82. Втюрин Б.В. Некоторые вопросы функциональной морфологии ультраструктур миокарда. Дис. докт. М., 1969, 414 с.
83. Струков А.И., Лушников Е.Ф., Горнак К.А. Гистохимия инфаркта миокарда. М., „Медицина“, 1967, 303 с.
84. Данилова К.М., Клибанер М.И., Баранов В.Н. Метаболизм и регенерация миокарда. „Арх. пат.“ 1971, I, с. 29-36.
85. Крыжановский Г.Н. Биоритмы и закон структурнофункциональной временной дискретности биологических процессов. В кн.: Биологические ритмы в механизмах компенсации нарушенных функций. М., 1973, 20-34.
86. Крыжановский Г.Н. Дистрофический процесс (некоторые аспекты проблемы). „Арх. пат.“ 1974; вып. 5, с. 3-12.
87. Pruvot E., Thonet G., Vesin J.M. et al. Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation 2000; 101: 2398 2404.
88. La Rovere M.T., Pinna G.D., Maestri R. et al. Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients. Circulation 2003; 107 (4): 565-570.
89. Frenneaux M.P. Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart 2004; 90: 1248 1255.
90. Akselrod S., Gordon D., Ubel F.A. et al. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220 222.
91. Malliani A., Pagani M., Lombardi F., Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482 492.
92. Montano N., Porta A., Malliani A. Evidence for central organization of cardiovascular rhythms. Ann NY Acad Sci 2001; 940: 299 306.
93. Pagani M., Montano N., Porta A. et al. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 1997; 95: 1441 1448.
94. Ando S., Dajani H.R., Floras J.S. Frequency domain characteristics of muscle sympathetic nerve activity in heart failure and healthy humans. Am J Physiol Regul Integr Comp Physiol 1997; 273: R205 R212.
Рецензия
Для цитирования:
Ревишвили А.Ш., Ломидзе Н.Н., Сунгатов Р.Ш., Хасанов И.Ш. УДАЛЕННАЯ ДИАГНОСТИКА И ИНТЕГРАЦИЯ МЕДИЦИНСКИХ ДАННЫХ ДЛЯ ПОВЫШЕНИЯ ЭФФЕКТИВНОСТИ ЭЛЕКТРОКАРДИОТЕРАПИИ. Вестник аритмологии. 2016;(85):5-18.
For citation:
Revishvili A.Sh., Lomidze N.N., Sungatov R.Sh., Khasanov I.Sh. REMOTE DIAGNOSIS AND INTEGRATION OF THE MEDICAL DATA FOR IMPROVEMENT OF EFFECTIVENESS OF ELECTROCARDIOTHERAPY. Journal of Arrhythmology. 2016;(85):5-18. (In Russ.)
Просмотров:
251
Послать статью по эл. почте 